Linked Life Data

2459765

Source:http://linkedlifedata.com/resource/pubmed/id/2459765

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1988-11-23
pubmed:abstractText
After reviewing the different pharmacological treatments of psychotic states, the author presents an evaluation of the clinical effectiveness of Clopixol Acutard (zuclopenthixol acetate in a viscoleo solution): 48% of the 23 patients (14 acute psychoses and 9 acute phases in chronic psychotic patients) respond well to the treatment, and only 17% suffered from important side effects, which demonstrates the good tolerance of the medication. Clopixol Acutard convinces by its rapid effect and with a mean of 5 injections leads to sedation, which is particularly helpful in patients with paranoid symptoms. The treatment interval, i.e. an injection every 2 or 3 days, is appreciated by the patients as well as by the therapists, for it establishes a less intrusive relationship.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0258-7661
pubmed:author
pubmed:issnType
Print
pubmed:volume
139
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
35-47
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1988
pubmed:articleTitle
[Use of Clopixol Acutard 50 and 100 mg (zuclopenthixol acetate) as a therapeutic drug in crisis at the Cery psychiatric hospital].
pubmed:affiliation
Clinique Psychiatrique Universitaire de Cery, Prilly.
pubmed:publicationType
Journal Article, English Abstract